Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss, as well as abdominal pain, fatigue, bloating, nausea, vomiting, and anemia. Olmesartan-induced enteropathy can develop months to years after the initiation of therapy and, in severe cases, can lead to hospitalization..
Related posts to sprue like enteropathy
FDA Drug Safety Communication: FDA approves label changes to include intestinal problems sprue-like enteropathy linked to blood .
Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?.
We describe five cases of sprue-like enteropathy during treatment with olmesartan, an angiotensin II receptor antagonist indicated for the treatment of hypertension..
The Medical Letter has provided trusted prescription drug information and drug facts since 1959.